These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 37844798)
1. Safety and performance of a hybrid closed-loop insulin delivery system with carbohydrate suggestion in adults with type 1 diabetes prone to hypoglycemia. Mesa A; Beneyto A; Martín-SanJosé JF; Viaplana J; Bondia J; Vehí J; Conget I; Giménez M Diabetes Res Clin Pract; 2023 Nov; 205():110956. PubMed ID: 37844798 [TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial. Renard E; Joubert M; Villard O; Dreves B; Reznik Y; Farret A; Place J; Breton MD; Kovatchev BP; Diabetes Care; 2023 Dec; 46(12):2180-2187. PubMed ID: 37729080 [TBL] [Abstract][Full Text] [Related]
4. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Sherr JL; Buckingham BA; Forlenza GP; Galderisi A; Ekhlaspour L; Wadwa RP; Carria L; Hsu L; Berget C; Peyser TA; Lee JB; O'Connor J; Dumais B; Huyett LM; Layne JE; Ly TT Diabetes Technol Ther; 2020 Mar; 22(3):174-184. PubMed ID: 31596130 [No Abstract] [Full Text] [Related]
5. Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms. Nattero-Chávez L; Lecumberri Pascual E; De La Calle E; Bayona Cebada A; Ruiz T; Quintero Tobar A; Lorenzo M; Sánchez C; Izquierdo A; Luque-Ramírez M; Escobar-Morreale HF Diabetes Res Clin Pract; 2023 May; 199():110627. PubMed ID: 36940793 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes. Garcia-Tirado J; Colmegna P; Villard O; Diaz JL; Esquivel-Zuniga R; Koravi CLK; Barnett CL; Oliveri MC; Fuller M; Brown SA; DeBoer MD; Breton MD Diabetes Care; 2023 Sep; 46(9):1652-1658. PubMed ID: 37478323 [TBL] [Abstract][Full Text] [Related]
7. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Lee MH; Vogrin S; Paldus B; Jones HM; Obeyesekere V; Sims C; Wyatt SA; Ward GM; McAuley SA; MacIsaac RJ; Krishnamurthy B; Sundararajan V; Jenkins AJ; O'Neal DN Diabetes Technol Ther; 2019 Sep; 21(9):499-506. PubMed ID: 31264889 [No Abstract] [Full Text] [Related]
8. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol. Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C; Benhalima K BMC Pregnancy Childbirth; 2023 Mar; 23(1):180. PubMed ID: 36927458 [TBL] [Abstract][Full Text] [Related]
9. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416 [TBL] [Abstract][Full Text] [Related]
10. Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes. Viñals C; Beneyto A; Martín-SanJosé JF; Furió-Novejarque C; Bertachi A; Bondia J; Vehi J; Conget I; Giménez M J Clin Endocrinol Metab; 2021 Jan; 106(1):55-63. PubMed ID: 32852548 [TBL] [Abstract][Full Text] [Related]
11. Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes. Gawrecki A; Zozulinska-Ziolkiewicz D; Michalak MA; Adamska A; Michalak M; Frackowiak U; Flotynska J; Pietrzak M; Czapla S; Gehr B; Araszkiewicz A PLoS One; 2021; 16(4):e0248965. PubMed ID: 33819289 [TBL] [Abstract][Full Text] [Related]
12. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial. Dovc K; Piona C; Yeşiltepe Mutlu G; Bratina N; Jenko Bizjan B; Lepej D; Nimri R; Atlas E; Muller I; Kordonouri O; Biester T; Danne T; Phillip M; Battelino T Diabetes Care; 2020 Jan; 43(1):29-36. PubMed ID: 31575640 [TBL] [Abstract][Full Text] [Related]
13. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes. Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077 [No Abstract] [Full Text] [Related]
14. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial. Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135 [TBL] [Abstract][Full Text] [Related]
15. Glycemic control metrics in a cohort of hospitalized patients with type 1 diabetes using hybrid closed-loop and advanced hybrid closed-loop systems. Gómez Medina AM; Henao-Carrillo DC; Yepes C; Silva J; Gómez González JA; Cortes D; Robledo S; Mejía G; Rondon M Diabetes Res Clin Pract; 2023 Oct; 204():110897. PubMed ID: 37678728 [TBL] [Abstract][Full Text] [Related]
16. First Use of Open-Source Automated Insulin Delivery AndroidAPS in Full Closed-Loop Scenario: Pancreas4ALL Randomized Pilot Study. Petruzelkova L; Neuman V; Plachy L; Kozak M; Obermannova B; Kolouskova S; Pruhova S; Sumnik Z Diabetes Technol Ther; 2023 May; 25(5):315-323. PubMed ID: 36826996 [No Abstract] [Full Text] [Related]
17. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424 [TBL] [Abstract][Full Text] [Related]
18. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443 [TBL] [Abstract][Full Text] [Related]
19. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting. Oriot P; Hermans MP J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333 [TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial. Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]